This product is intended strictly for laboratory research and not approved for human consumption by any regulatory agency, including the FDA 3
A Cochrane systematic review of NAC for COPD exacerbations (39 RCTs, n=7,436) found that NAC and other mucolytics significantly reduced the frequency of acute exacerbations (OR 0.75, 95% CI 0.62-0.92) (Poole et al., Cochrane Database Syst Rev, 2019) [43]
You are pregnant or planning pregnancy
When evaluating side effects, the following frequencies are used as a basis: Very common: more than 1 in 10 people Common: less than 1 in 10, but more than 1 in 100 patients Uncommon: less than 1 in 100, but more than 1 in 1000 patients Rare: less than 1 in 1,000 but more than 1 in 10,000 patients Very rare: less than 1 in 10,000 patients treated, or unknown
But the support is preclinical and based on cell studies and melanocortin biology, not human dermatology trials
What Causes Pernicious Anemia